Dustin S Sjuts Insider Trading $RVNC Revance Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dustin S Sjuts.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dustin S Sjuts. Dustin S Sjuts is Chief Commercial Officer in Revance Therapeutics, Inc. ($RVNC).
Dustin S Sjuts in Revance Therapeutics, Inc.
Trading Symbol: RVNCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dustin S Sjuts: Chief Commercial Officer
Holdings: 65,098 shares
Current Value: $1,347,529
Latest Transaction: Apr 16 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Dustin S Sjuts in Revance Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 16 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 28.16 | 411 | 11,574 | 65,098 | 65.5 K to 65.1 K (-0.63 %) |
Feb 19 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 28.97 | 2,135 | 61,851 | 65,509 | 67.6 K to 65.5 K (-3.16 %) |
Feb 19 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 28.97 | 275 | 7,967 | 67,644 | 67.9 K to 67.6 K (-0.40 %) |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Option Exercise | A | 28.01 | 40,925 | 1,146,309 | 40,925 | |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Grant | A | 0.00 | 22,620 | 0 | 67,919 | 45.3 K to 67.9 K (+49.93 %) |
Jan 04 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Buy | J | 21.36 | 348 | 7,433 | 45,299 | 45 K to 45.3 K (+0.77 %) |
Dec 22 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 26.75 | 562 | 15,034 | 44,951 | 45.5 K to 45 K (-1.23 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 25.14 | 6,051 | 152,122 | 45,513 | 51.6 K to 45.5 K (-11.73 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Grant | A | 0.00 | 17,500 | 0 | 51,564 | 34.1 K to 51.6 K (+51.37 %) |
Jul 02 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Buy | J | 13.80 | 1,000 | 13,796 | 34,064 | 33.1 K to 34.1 K (+3.02 %) |
Apr 17 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 14.80 | 432 | 6,394 | 33,064 | 33.5 K to 33.1 K (-1.29 %) |
Feb 19 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 25.33 | 288 | 7,295 | 33,496 | 33.8 K to 33.5 K (-0.85 %) |
Jan 24 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Option Exercise | A | 22.32 | 100,000 | 2,232,000 | 100,000 | |
Jan 24 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Grant | A | 0.00 | 20,000 | 0 | 33,784 | 13.8 K to 33.8 K (+145.10 %) |
Jan 03 2020 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Buy | J | 10.82 | 382 | 4,133 | 13,784 | 13.4 K to 13.8 K (+2.85 %) |
Dec 17 2019 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 15.99 | 576 | 9,210 | 11,492 | 12.1 K to 11.5 K (-4.77 %) |
Page: 1